Welcome to Open Science
Contact Us
Home Books Journals Submission Open Science Join Us News
Critical Review of Assisted Reproductive Technology and the Nigerian Invitro Fertilisation Situation
Current Issue
Volume 7, 2020
Issue 2 (June)
Pages: 12-23   |   Vol. 7, No. 2, June 2020   |   Follow on         
Paper in PDF Downloads: 48   Since Jul. 23, 2020 Views: 594   Since Jul. 23, 2020
Authors
[1]
Dic-Ijiewere Ebenezer Oseremen, Department of Chemical Pathology, Ambrose Alli University, Ekpoma, Nigeria.
[2]
Osadolor Humphrey B, Department of Medical Laboratory Science, University of Benin, Benin, Nigeria.
Abstract
Invitro fertilisation (IVF) technique involves a process of hormonal monitoring and hormonal stimulation of a woman's ovulatory process, for the purpose of removal of an ovum or ova (egg or eggs) from the woman's ovaries. It also includes the assessment of semen quality suitable enough to fertilise the ovum or ova in a liquid medium in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2–6 days before transfer to the same or another woman's uterus. There are other complex molecular aspects of IVF known as the preimplantation genetic diagnosis (PGD) which is carried out to rule out presence of genetic disorders, as well as egg donation or surrogacy compatibility. The IVF process is a multimillion naira/dollar medical technology. Unlike the simpler process of artificial insemination -- in which sperm is placed in the uterus and conception happens otherwise normally -- IVF involves combining eggs and sperm outside the body in a laboratory. Once an embryo or embryos form, they are then placed in the uterus. IVF is a complex and expensive procedure; only a few couples with infertility seek it out either as a result of religion, culture, ignorance, fear, cost or stigmatisation. The Nigerian IVF system is still an emerging domain, with most of the activities of the IVF technology providers still highly confidential making it difficult to ascertain the challenges, successes and failures of the Nigerian IVF system.
Keywords
Invitro Fertilisation, Assisted, Reproduction, Sperm, Egg, Nigeria
Reference
[1]
van Loendersloot, L. L., van Wely, M., Limpens, J., Bossuyt, P. M., Repping, S., van der Veen, F. (2010). "Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis". Human Reproduction Update. 16 (6): 577–589.
[2]
Clinic Summary Report (2012): Society for Reproductive Medicine. Retrieved 2014-11-06.
[3]
Schulman, J. D. (2010): Robert G. Edwards – A Personal Viewpoint, CreateSpace Independent Publishing Platform, ISBN 1456320750.
[4]
Guardian Newspaper (2014). 4,000 babies born through IVF in Nigeria. Retrieved from http://news.logbaby.com in August 2019.
[5]
Broer, S. L., van Disseldorp, J., Broeze, K. A., Dolleman, M., Opmeer, B. C., Bossuyt, P., Eijkemans, M. J., Mol, B. W., Broekmans, F. J. (2012): "Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach". Human Reproduction Update. 19 (1): 26–36.
[6]
Iliodromiti, S., Kelsey, T. W., Wu, O., Anderson, R. A., Nelson, S. M. (2014): "The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature". Human Reproduction Update. 20 (4): 560–570.
[7]
Simon, L., Brunborg, G., Stevenson, M., Lutton, D., McManus, J., Lewis, S. E. (2010): "Clinical significance of sperm DNA damage in assisted reproduction outcome". Human Reproductive. 25 (7): 1594–608.
[8]
Gleicher, N., Weghofer, A., Lee, I. H., Barad, D. H. (2010). "FMR1 Genotype with Autoimmunity-Associated Polycystic Ovary-Like Phenotype and Decreased Pregnancy Chance". PLoS ONE. 5 (12): e15303.
[9]
Venetis, C. A., Kolibianakis, E. M., Bosdou, J. K., Tarlatzis, B. C. (2013): "Progesterone elevation and probability of pregnancy after IVF: A systematic review and meta-analysis of over 60 000 cycles". Human Reproduction Update. 19 (5): 433–457.
[10]
Fragouli, E., Lalioti, M. D., Wells, D. (2013): "The transcriptome of follicular cells: Biological insights and clinical implications for the treatment of infertility". Human Reproduction Update. 20 (1): 1–11.
[11]
Kasius, A., Smit, J. G., Torrance, H. L., Eijkemans, M. J. C., Mol, B. W., Opmeer, B. C., Broekmans, F. J. M. (2014). "Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis". Human Reproduction Update. 20 (4): 530–541.
[12]
de La Rochebrochard, E., Quelen, C., Peikrishvili, R., Guibert, J., Bouyer, J. (2008). "Long-term outcome of parenthood project during in vitro fertilization and after discontinuation of unsuccessful in vitro fertilization". Fertility and Sterility. 92 (1): 149–56.
[13]
Groeneveld, E., Broeze, K. A., Lambers, M. J., Haapsamo, M., Dirckx, K., Schoot, B. C., Salle, B., Duvan, C. I., Schats, R., Mol, B. W., Hompes, P. G. (2011). "Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA)". Human Reproduction Update. 17 (4): 501–509.
[14]
Siristatidis, C. S., Basios, G., Pergialiotis, V., Vogiatzi, P. (2016). "Aspirin for in vitro fertilisation". The Cochrane Database of Systematic Reviews. 11: CD004832.
[15]
Farquhar, C., Rishworth, J. R., Brown, J., Nelen, W. L., Marjoribanks, J. (2015). "Assisted reproductive technology: an overview of Cochrane Reviews". TheCochrane Database System Reviews. 7: CD010537.
[16]
La Marca, A. and Sunkara, S. K. (2014): "Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice". Human Reproduction Update. 20 (1): 124–40.
[17]
Quinn, M. M., Cakmak, H., Letourneau, J. M. (2017): Response to ovarian stimulation is not impacted by a breast cancer diagnosis. Human Reproduction. 32 (3): 568–74.
[18]
Mai, Q., Hu, X., Yang, G. (2017): Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial. American Journal of Obstetrics and Gynecololgy. 216 (1): 42.
[19]
Goldrat, O., Gervy, C., Englert, Y. (2015): Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. Human Reproduction. 30 (9): 2184–9. 10.
[20]
Pereira, N., Hancock, K., Cordeiro, C. N. (2016): Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes. Gynecological Endocrinology. 32 (10): 823–6.
[21]
Casper, R., Haas, J., Hsieh, T., Bassil, R., and Mehta, C. (2017): Recent advances in in vitro fertilization. F1000 Res. 6: 1616.
[22]
Allersma, T., Farquhar, C., Cantineau, A. E. (2013): "Natural cycle in vitro fertilisation (IVF) for subfertile couples". The Cochrane Database System Reviews. 8: CD010550.
[23]
Evans, J., Hannan, N. J., Edgell, T. A., Vollenhoven, B. J., Lutjen, P. J., Osianlis, T., Salamonsen, L. A., Rombauts, L. J. F. (2014). "Fresh versus frozen embryo transfer: backing clinical decisions with scientific and clinical evidence". Human Reproduction Update. 20 (6): 808–821.
[24]
Nargund, G. (2009). "Natural/mild assisted reproductive technologies: Reducing cost and increasing safety". Women's Health. 5 (4): 359–360.
[25]
Heijnen, E. M., Eijkemans, M. J., De Klerk, C., Polinder, S., Beckers, N. G., Klinkert, E. R., Broekmans, F. J., Passchier, J., Te Velde, E. R., Macklon, N. S., Fauser, B. C. (2007): "A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial". Lancet. 369 (9563): 743–9.
[26]
Fauser, B. C., Nargund, G., Andersen, A. N., Norman, R., Tarlatzis, B., Boivin, J., Ledger, W. (2010): "Mild ovarian stimulation for IVF: 10 years later". Human Reproduction. 25 (11): 2678–2684.
[27]
Transvaginal ovum retrieval. https://docs.IVF/colourbox/index.html
[28]
Peter, K. (2004): HCG Injection after Ovulation Induction with Clomiphene Citrate at Medscape.
[29]
Humaidan, P., Ko, l S., Papanikolaou, E. G. (2011): "GnRH agonist for triggering of final oocyte maturation: time for a change of practice?". Human Reproduction Update. 17 (4): 510–524.
[30]
Murto, T., Bjuresten, K., Landgren, B. and Stavreus-Evers, A. (2013): Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertility. Reproductive Biology and Endocrinology. 11: 61-64.
[31]
Zhang, X. D., Liu, J. X., Liu, W. W., Gao, Y., Han, W., Xiong, S., Wu, L. H., Huang, G. N. (2013): "Time of insemination culture and outcomes of in vitro fertilization: A systematic review and meta-analysis". Human Reproduction Update. 19 (6): 685–695.
[32]
Dar, S., Lazer, T., Shah, P. S., Librach, C. L. (2014): "Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis". Human Reproductive Update. 20 (3): 439–48.
[33]
Rebmann, V., Switala, M., Eue, I., Grosse-Wilde, H. (2010): "Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study". Human Reproduction. 25 (7): 1691–8.
[34]
Meseguer, M., Rubio, I., Cruz, M., Basile, N., Marcos, J., Requena, A. (2012): "Embryo incubation and selection in a time-lapse monitoring system improves pregnancy outcome compared with a standard incubator: A retrospective cohort study". Fertility and Sterility. 98 (6): 1481–1489.e10.
[35]
Armstrong, S., Arroll, N., Cree, L. M., Jordan, V., Farquhar, C. (2015): "Time-lapse systems for embryo incubation and assessment in assisted reproduction". The Cochrane Database of Systematic Reviews. 2: CD011320.
[36]
Mastenbroek, S., Twisk, M., van der Veen, F., Repping, S. (2011): "Preimplantation genetic screening: A systematic review and meta-analysis of RCTs". Human Reproduction Update. 17 (4): 454–466.
[37]
Britten, N. (2011): Saviour Sibling Cures Sick Older Brother The Daily Telegraph, Health News, 7 May 2011. Retrieved 8 May 2011.
[38]
French, D. B., Sabanegh, E. S., Goldfarb, J., Desai, N. (2010): "Does severe teratozoospermia affect blastocyst formation, live birth rate, and other clinical outcome parameters in ICSI cycles?". Fertility Sterility. 93 (4): 1097–1103.
[39]
Illmensee, K., Levanduski, M., Vidali, A., Husami, N., Goudas, V. T. (2009): "Human embryo twinning with applications in reproductive medicine". Fertility and Sterility. 93 (2): 423–7.
[40]
Fauser, B. C., Diedrich, K., Bouchard, P., Domínguez, F., Matzuk, M., Franks, S., Hamamah, S., Simón, C., Devroey, P., Ezcurra, D., Howles, C. M. (2011): "Contemporary genetic technologies and female reproduction". Human Reproduction Update. 17 (6): 829–847.
[41]
Knapton, S. (2018): New British test for IVF patients could increase chance of conception by 75%. Science Editor, Baltimore. Copyright of Telegraph Media Group Limited 2018.
[42]
Dagan W. (2017): Excessive levels of mitochondrial DNA (mtDNA) will consequently not produce a viable pregnancy. The NIHR Oxford Biomedical Research Centre, Oxford University.
[43]
van der Linden, M., Buckingham, K., Farquhar, C., Kremer, J. A., Metwally, M. (2015). "Luteal phase support for assisted reproduction cycles". The Cochrane Database System Reviews (7): CD009154.
[44]
Kyrou, D., Kolibianakis, E. M., Fatemi, H. M., Tarlatzi, T. B., Devroey, P., Tarlatzis, B. C. (2011): "Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: A systematic review and meta-analysis". Human Reproduction Update. 17 (6): 734–740.
[45]
Shahin, A. (2007). The problem of IVF cost in developing countries: has natural cycle IVF a place?Reproductive Biomedicine Online. 15 (1). Pp. 51-56. Retrieved from www.rbmonline.com /Article/2850 on 22 May 2007.
[46]
NIGERIAN PRICE (2017): IVF prices in Nigeria. https://nigerianprice.com/cost-of-ivf-in-nigeria.
[47]
Ola, T. M. (2012): Assisted Reproductie Technology in Nigeria: Flawed or favoured? In International Journal of Social Sciences and Humanities. 2 (4): 331-334.
[48]
Osazuwa, H. (2013). Controversies in In-Vitro Fertilisation. A paper delivered at NISA Premier Hospital, Jabi, Abuja.
[49]
Jha, A. (2007): "Winston: IVF clinics corrupt and greedy". The Guardian. London of 31 May 2007.
[50]
Warren, M. A. (1988): "IVF and women's interests: an analysis of feminist concerns". Bioethics. 2 (1): 37–57.
[51]
Pope Benedict XVI (2008): "Pope Benedict XVI Declares Embryos Developed for in Vitro Fertilization Have Right to Life", Medical news today, archived from the original on 29 December 2008.
[52]
Pope Paul VI (1968): "Humanae Vitae: Encyclical of Pope Paul VI on the Regulation of Birth, sec 12". Rome: Vatican. Retrieved 25 November 2008.
[53]
Inhorn, M. C. (2006). "Making Muslim babies: IVF and gamete donation in Sunni versus Shi'a Islam". Culture Medicine and Psychiatry. pp. 427–50.
[54]
Drah, B. (2012):"Orphans in Sub-Saharan Africa: The Crisis, the Interventions, and the Anthropologist". Africa Today. 59 (2 (Winter 2012)): 3–21.
Open Science Scholarly Journals
Open Science is a peer-reviewed platform, the journals of which cover a wide range of academic disciplines and serve the world's research and scholarly communities. Upon acceptance, Open Science Journals will be immediately and permanently free for everyone to read and download.
CONTACT US
Office Address:
228 Park Ave., S#45956, New York, NY 10003
Phone: +(001)(347)535 0661
E-mail:
LET'S GET IN TOUCH
Name
E-mail
Subject
Message
SEND MASSAGE
Copyright © 2013-, Open Science Publishers - All Rights Reserved